Details for log entry 33020364

13:08, 19 July 2022: Chrisvanlang (talk | contribs) triggered filter 1,030, performing the action "edit" on Draft:Philip Greenberg. Actions taken: none; Filter description: Adding URLs with tracking parameters (examine | diff)

Changes made in edit

{{AfC topic|blp}}
{{AfC topic|blp}}


{{Infobox scientist
Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the University of Washington and Head of Program in Immunology at Fred Hutch Cancer Center.<ref>{{Cite web |title=Philip D. Greenberg, M.D. |url=https://www.immunology.washington.edu/faculty/primary-joint-faculty/greenberg/ |access-date=2022-02-27 |website=Department of Immunology |publisher=[[University of Washington]] |language=en}}</ref><ref>{{Cite web |title=Philip Greenberg, M.D. |url=https://www.fredhutch.org/en/faculty-lab-directory/greenberg-philip.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref>
| honorific_prefix =
| name = Philip Greenberg
| honorific_suffix =
| native_name =
| native_name_lang =
| image = <!--(filename only, i.e. without "File:" prefix)-->
| image_size =
| image_upright =
| alt =
| caption =
| birth_name = <!-- if different from "name" -->
| birth_date = <!--{{birth date |YYYY|MM|DD}}-->
| birth_place =
| death_date = <!--{{death date and age |YYYY|MM|DD |YYYY|MM|DD}} (death date then birth date)-->
| death_place =
| death_cause =
| resting_place =
| resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}-->
| other_names =
| siglum =
| pronounce =
| citizenship = <!-- use only when necessary per [[WP:INFONAT]] -->
| nationality = <!-- use only when necessary per [[WP:INFONAT]] -->
| fields = [[Hematology]]
| workplaces =
| patrons =
| education = [[Washington University]],
| alma_mater =
| thesis_title = <!--(or | thesis1_title = and | thesis2_title = )-->
| thesis_url = <!--(or | thesis1_url = and | thesis2_url = )-->
| thesis_year = <!--(or | thesis1_year = and | thesis2_year = )-->
| doctoral_advisor = <!--(or | doctoral_advisors = )-->
| academic_advisors =
| doctoral_students =
| notable_students =
| known_for =
| influences =
| influenced =
| awards =
| author_abbrev_bot =
| author_abbrev_zoo =
| spouse = <!--(or | spouses = )-->
| partner = <!--(or | partners = )-->
| children =
| parents =
| father =
| mother =
| relatives =
| signature = <!--(filename only)-->
| signature_alt =
| website = <!--{{URL|www.example.com}}-->
| footnotes =
}}


Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the [[University of Washington]] and Head of Program in Immunology at [[Fred Hutchinson Cancer Research Center]]. His research is centered around [[T cell]] biology and therapeutic cell therapies.<ref>{{cite news |title=Dr. Phil Greenberg named 2018 Leader in Health Care |url=https://www.fredhutch.org/en/news/center-news/2018/03/phil-greenberg-leader-health-care-award.html?fbclid=IwAR2b4ajtNMWgnbFaXRtr8XaZ7AfcV0zOaJ3iJ38eJr22A3EH4kfB5aDZYes |work=Fred Hutch |date=2 March 2018 |language=en}}</ref> He is a co-founder of [[Juno Therapeutics]] and Affini-T.<ref>{{cite news |title=A new biotech startup looks to sidestep a key problem with CAR-T cancer therapies |url=https://www.statnews.com/2022/01/13/cancer-immunotherapy-tcr-cart-affinit/ |work=STAT |date=13 January 2022}}</ref><ref>{{cite news |title=Leading cancer research centers team up to launch biotech startup focused on cancer immunotherapy |url=https://www.fiercebiotech.com/biotech/leading-cancer-research-centers-team-up-to-launch-biotech-startup-focused-on-cancer |work=Fierce Biotech |date=4 December 2013 |language=en}}</ref>
Dr. Philip Greenberg graduated from Washington University with at degree in Biology. He received his M.D. summa cum laude in 1971 from the State University of New York, Downstate Medical Center. After completing postdoctoral training at the University of California at San Diego , he joined the Fred Hutchinson Cancer Research Center and the Division of Oncology at the University of Washington in 1976.


==Education and Research==
Awards
Philip graduated from [[Washington University]] with at degree in Biology. He received his M.D. summa cum laude in 1971 from [[SUNY Downstate Medical Center]]. After completing postdoctoral training at the [[University of California at San Diego]], he joined the Fred Hutchinson Cancer Research Center and the Division of Oncology at the University of Washington in 1976.<ref>{{cite web |url=https://www.pmwcintl.com/speaker/philip-greenberg_fred-hutchinson-cancer-research-center_2020sv/}}</ref> His research is focused on T cell adoptive immune therapy. His group demonstrated the potential of isolating antigen-specific T cells and growing them to perform in vivo activity against a disease. <ref name="ASH Award">{{cite web |title=Philip Greenberg, MD, to Present the 2019 American Society of Hematology E. Donnall Thomas Lecture |url=https://www.hematology.org/newsroom/press-releases/2019/2019-e-donnall-thomas-lecture |website=www.hematology.org |language=en}}</ref><ref>{{cite journal |last1=Riddell |first1=Stanley R. |last2=Watanabe |first2=Kathe S. |last3=Goodrich |first3=James M. |last4=Li |first4=Cheng R. |last5=Agha |first5=Mounzer E. |last6=Greenberg |first6=Philip D. |title=Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones |journal=Science |date=10 July 1992 |volume=257 |issue=5067 |pages=238–241 |doi=10.1126/science.1352912}}</ref><ref>{{cite journal |last1=Walter |first1=Elizabeth A. |last2=Greenberg |first2=Philip D. |last3=Gilbert |first3=Mark J. |last4=Finch |first4=Rosalynde J. |last5=Watanabe |first5=Käthe S. |last6=Thomas |first6=E. Donnall |last7=Riddell |first7=Stanley R. |title=Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor |journal=New England Journal of Medicine |date=19 October 1995 |volume=333 |issue=16 |pages=1038–1044 |doi=10.1056/NEJM199510193331603}}</ref> His group is now working on re-engineering T cells to produce [[T cell receptor T cell therapy|TCR-T]] that will work for other non-leukemia malignancies.<ref name="Spotlight on Phil Greenberg">{{cite web |title=Spotlight on Phil Greenberg |url=https://www.fredhutch.org/en/faculty-lab-directory/greenberg-philip/greenberg-spotlight.html?&link=sfb |website=Fred Hutch |language=en}}</ref>


==Awards==
* 2019 E.Donnall Thomas Lecture and Prize, American Society of Hematology

* 2019 elected a Distinguished Fellow of the American Association of Immunologists<ref>{{Cite web |date=2019-04-19 |title=Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists |url=https://www.fredhutch.org/en/news/center-news/2019/04/greenberg-elected-american-association-immunologists.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref>
* 2019 E. Donnall Thomas Lecture and Prize, [[American Society of Hematology]]<ref name="ASH Award" />
* 2018 awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lectureship<ref>https://centernet.fredhutch.org/cn/n/2018/11/cancer-immunotherapy-sitc-awards.html</ref>
* 2019 Elected a Distinguished Fellow of the American Association of Immunologists<ref>{{Cite web |date=2019-04-19 |title=Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists |url=https://www.fredhutch.org/en/news/center-news/2019/04/greenberg-elected-american-association-immunologists.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref>
* 2018 awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lectureship<ref>{{cite web |url=https://www.sitcancer.org/2018/program/annual-meeting/keynotes/greenberg}}</ref>
* 2018 Gold Award for Achievement in Medical Research, Seattle Business Magazine
* 2018 Gold Award for Achievement in Medical Research, Seattle Business Magazine
* 2017-2020 elected Board of Directors, AACR<ref>www.fredhutch.org/en/news/center-news/2017/03/greenberg-aacr-board.html</ref>
* 2017-2020 elected Board of Directors, AACR<ref>www.fredhutch.org/en/news/center-news/2017/03/greenberg-aacr-board.html</ref>
* 2007 Elected Fellow, American Association for the Advancement of Science
* 2007 Elected Fellow, American Association for the Advancement of Science
* 1998 Elected Member, Association of American Physicians
* 1998 Elected Member, Association of American Physicians
* 1991-2007 National Institutes of Health MERIT Award
* 1991, 2007 National Institutes of Health MERIT Award
* 1987 Elected Member, American Society for Clinical Investigation
* 1987 Elected Member, American Society for Clinical Investigation
* 1978-1981 American Cancer Society Junior Clinical Faculty Fellowship
* 1978-1981 American Cancer Society Junior Clinical Faculty Fellowship


== References ==
== References ==
<!-- Inline citations added to your article will automatically display here. See en.wikipedia.org/wiki/WP:REFB for instructions on how to add citations. -->
<!-- Inline citations added to your article will automatically display here. See en.wikipedia.org/wiki/WP:REFB for instructions on how to add citations. -->
{{reflist}}
{{reflist}}

{{Authority control}}

Action parameters

VariableValue
Edit count of the user (user_editcount)
2028
Name of the user account (user_name)
'Chrisvanlang'
Age of the user account (user_age)
432033454
Groups (including implicit) the user is in (user_groups)
[ 0 => 'extendedconfirmed', 1 => '*', 2 => 'user', 3 => 'autoconfirmed' ]
Rights that the user has (user_rights)
[ 0 => 'extendedconfirmed', 1 => 'createaccount', 2 => 'read', 3 => 'edit', 4 => 'createtalk', 5 => 'writeapi', 6 => 'viewmywatchlist', 7 => 'editmywatchlist', 8 => 'viewmyprivateinfo', 9 => 'editmyprivateinfo', 10 => 'editmyoptions', 11 => 'abusefilter-log-detail', 12 => 'urlshortener-create-url', 13 => 'centralauth-merge', 14 => 'abusefilter-view', 15 => 'abusefilter-log', 16 => 'vipsscaler-test', 17 => 'collectionsaveasuserpage', 18 => 'reupload-own', 19 => 'move-rootuserpages', 20 => 'createpage', 21 => 'minoredit', 22 => 'editmyusercss', 23 => 'editmyuserjson', 24 => 'editmyuserjs', 25 => 'purge', 26 => 'sendemail', 27 => 'applychangetags', 28 => 'spamblacklistlog', 29 => 'mwoauthmanagemygrants', 30 => 'reupload', 31 => 'upload', 32 => 'move', 33 => 'autoconfirmed', 34 => 'editsemiprotected', 35 => 'skipcaptcha', 36 => 'ipinfo', 37 => 'ipinfo-view-basic', 38 => 'transcode-reset', 39 => 'transcode-status', 40 => 'createpagemainns', 41 => 'movestable', 42 => 'autoreview' ]
Whether the user is editing from mobile app (user_app)
false
Whether or not a user is editing through the mobile interface (user_mobile)
false
Page ID (page_id)
70177808
Page namespace (page_namespace)
118
Page title without namespace (page_title)
'Philip Greenberg'
Full page title (page_prefixedtitle)
'Draft:Philip Greenberg'
Edit protection level of the page (page_restrictions_edit)
[]
Page age in seconds (page_age)
12310747
Action (action)
'edit'
Edit summary/reason (summary)
''
Old content model (old_content_model)
'wikitext'
New content model (new_content_model)
'wikitext'
Old page wikitext, before the edit (old_wikitext)
'{{AFC submission|d|bio|u=Greenberg007|ns=118|decliner=Dan arndt|declinets=20220227041105|reason2=ilc|ts=20220227013344}} <!-- Do not remove this line! --> {{AFC comment|1=Fails [[WP: ANYBIO]], is essentially a [[WP:AUTOBIO]] / [[WP:SELFPROMOTION]]. [[User:Dan arndt|Dan arndt]] ([[User talk:Dan arndt|talk]]) 04:11, 27 February 2022 (UTC)}} ---- {{Short description|Medical Oncology and Immunology Professor}} {{COI|date=February 2022}} {{Primary sources|date=February 2022}} {{Draft topics|biography|north-america|stem}} {{AfC topic|blp}} Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the University of Washington and Head of Program in Immunology at Fred Hutch Cancer Center.<ref>{{Cite web |title=Philip D. Greenberg, M.D. |url=https://www.immunology.washington.edu/faculty/primary-joint-faculty/greenberg/ |access-date=2022-02-27 |website=Department of Immunology |publisher=[[University of Washington]] |language=en}}</ref><ref>{{Cite web |title=Philip Greenberg, M.D. |url=https://www.fredhutch.org/en/faculty-lab-directory/greenberg-philip.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref> Dr. Philip Greenberg graduated from Washington University with at degree in Biology. He received his M.D. summa cum laude in 1971 from the State University of New York, Downstate Medical Center. After completing postdoctoral training at the University of California at San Diego , he joined the Fred Hutchinson Cancer Research Center and the Division of Oncology at the University of Washington in 1976. Awards * 2019 E.Donnall Thomas Lecture and Prize, American Society of Hematology * 2019 elected a Distinguished Fellow of the American Association of Immunologists<ref>{{Cite web |date=2019-04-19 |title=Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists |url=https://www.fredhutch.org/en/news/center-news/2019/04/greenberg-elected-american-association-immunologists.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref> * 2018 awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lectureship<ref>https://centernet.fredhutch.org/cn/n/2018/11/cancer-immunotherapy-sitc-awards.html</ref> * 2018 Gold Award for Achievement in Medical Research, Seattle Business Magazine * 2017-2020 elected Board of Directors, AACR<ref>www.fredhutch.org/en/news/center-news/2017/03/greenberg-aacr-board.html</ref> * 2015 Editor-In-Chief, Cancer Immunology Research, AACR<ref>www.fredhutch.org/en/news/center-news/2015/10/good-news-cti-overbaugh-orozco-greenberg-main.html</ref> * 2011 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, Cancer Research Institute<ref>www.fredhutch.org/en/news/center-news/2011/09/Greenberg-immunotherapy-award.html</ref> * 2008 Elected Fellow, American College of Physicians * 2007 Elected Fellow, American Association for the Advancement of Science * 1998 Elected Member, Association of American Physicians * 1991-2007 National Institutes of Health MERIT Award * 1987 Elected Member, American Society for Clinical Investigation * 1978-1981 American Cancer Society Junior Clinical Faculty Fellowship == References == <!-- Inline citations added to your article will automatically display here. See en.wikipedia.org/wiki/WP:REFB for instructions on how to add citations. --> {{reflist}}'
New page wikitext, after the edit (new_wikitext)
'{{AFC submission|d|bio|u=Greenberg007|ns=118|decliner=Dan arndt|declinets=20220227041105|reason2=ilc|ts=20220227013344}} <!-- Do not remove this line! --> {{AFC comment|1=Fails [[WP: ANYBIO]], is essentially a [[WP:AUTOBIO]] / [[WP:SELFPROMOTION]]. [[User:Dan arndt|Dan arndt]] ([[User talk:Dan arndt|talk]]) 04:11, 27 February 2022 (UTC)}} ---- {{Short description|Medical Oncology and Immunology Professor}} {{COI|date=February 2022}} {{Primary sources|date=February 2022}} {{Draft topics|biography|north-america|stem}} {{AfC topic|blp}} {{Infobox scientist | honorific_prefix = | name = Philip Greenberg | honorific_suffix = | native_name = | native_name_lang = | image = <!--(filename only, i.e. without "File:" prefix)--> | image_size = | image_upright = | alt = | caption = | birth_name = <!-- if different from "name" --> | birth_date = <!--{{birth date |YYYY|MM|DD}}--> | birth_place = | death_date = <!--{{death date and age |YYYY|MM|DD |YYYY|MM|DD}} (death date then birth date)--> | death_place = | death_cause = | resting_place = | resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}--> | other_names = | siglum = | pronounce = | citizenship = <!-- use only when necessary per [[WP:INFONAT]] --> | nationality = <!-- use only when necessary per [[WP:INFONAT]] --> | fields = [[Hematology]] | workplaces = | patrons = | education = [[Washington University]], | alma_mater = | thesis_title = <!--(or | thesis1_title = and | thesis2_title = )--> | thesis_url = <!--(or | thesis1_url = and | thesis2_url = )--> | thesis_year = <!--(or | thesis1_year = and | thesis2_year = )--> | doctoral_advisor = <!--(or | doctoral_advisors = )--> | academic_advisors = | doctoral_students = | notable_students = | known_for = | influences = | influenced = | awards = | author_abbrev_bot = | author_abbrev_zoo = | spouse = <!--(or | spouses = )--> | partner = <!--(or | partners = )--> | children = | parents = | father = | mother = | relatives = | signature = <!--(filename only)--> | signature_alt = | website = <!--{{URL|www.example.com}}--> | footnotes = }} Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the [[University of Washington]] and Head of Program in Immunology at [[Fred Hutchinson Cancer Research Center]]. His research is centered around [[T cell]] biology and therapeutic cell therapies.<ref>{{cite news |title=Dr. Phil Greenberg named 2018 Leader in Health Care |url=https://www.fredhutch.org/en/news/center-news/2018/03/phil-greenberg-leader-health-care-award.html?fbclid=IwAR2b4ajtNMWgnbFaXRtr8XaZ7AfcV0zOaJ3iJ38eJr22A3EH4kfB5aDZYes |work=Fred Hutch |date=2 March 2018 |language=en}}</ref> He is a co-founder of [[Juno Therapeutics]] and Affini-T.<ref>{{cite news |title=A new biotech startup looks to sidestep a key problem with CAR-T cancer therapies |url=https://www.statnews.com/2022/01/13/cancer-immunotherapy-tcr-cart-affinit/ |work=STAT |date=13 January 2022}}</ref><ref>{{cite news |title=Leading cancer research centers team up to launch biotech startup focused on cancer immunotherapy |url=https://www.fiercebiotech.com/biotech/leading-cancer-research-centers-team-up-to-launch-biotech-startup-focused-on-cancer |work=Fierce Biotech |date=4 December 2013 |language=en}}</ref> ==Education and Research== Philip graduated from [[Washington University]] with at degree in Biology. He received his M.D. summa cum laude in 1971 from [[SUNY Downstate Medical Center]]. After completing postdoctoral training at the [[University of California at San Diego]], he joined the Fred Hutchinson Cancer Research Center and the Division of Oncology at the University of Washington in 1976.<ref>{{cite web |url=https://www.pmwcintl.com/speaker/philip-greenberg_fred-hutchinson-cancer-research-center_2020sv/}}</ref> His research is focused on T cell adoptive immune therapy. His group demonstrated the potential of isolating antigen-specific T cells and growing them to perform in vivo activity against a disease. <ref name="ASH Award">{{cite web |title=Philip Greenberg, MD, to Present the 2019 American Society of Hematology E. Donnall Thomas Lecture |url=https://www.hematology.org/newsroom/press-releases/2019/2019-e-donnall-thomas-lecture |website=www.hematology.org |language=en}}</ref><ref>{{cite journal |last1=Riddell |first1=Stanley R. |last2=Watanabe |first2=Kathe S. |last3=Goodrich |first3=James M. |last4=Li |first4=Cheng R. |last5=Agha |first5=Mounzer E. |last6=Greenberg |first6=Philip D. |title=Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones |journal=Science |date=10 July 1992 |volume=257 |issue=5067 |pages=238–241 |doi=10.1126/science.1352912}}</ref><ref>{{cite journal |last1=Walter |first1=Elizabeth A. |last2=Greenberg |first2=Philip D. |last3=Gilbert |first3=Mark J. |last4=Finch |first4=Rosalynde J. |last5=Watanabe |first5=Käthe S. |last6=Thomas |first6=E. Donnall |last7=Riddell |first7=Stanley R. |title=Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor |journal=New England Journal of Medicine |date=19 October 1995 |volume=333 |issue=16 |pages=1038–1044 |doi=10.1056/NEJM199510193331603}}</ref> His group is now working on re-engineering T cells to produce [[T cell receptor T cell therapy|TCR-T]] that will work for other non-leukemia malignancies.<ref name="Spotlight on Phil Greenberg">{{cite web |title=Spotlight on Phil Greenberg |url=https://www.fredhutch.org/en/faculty-lab-directory/greenberg-philip/greenberg-spotlight.html?&link=sfb |website=Fred Hutch |language=en}}</ref> ==Awards== * 2019 E. Donnall Thomas Lecture and Prize, [[American Society of Hematology]]<ref name="ASH Award" /> * 2019 Elected a Distinguished Fellow of the American Association of Immunologists<ref>{{Cite web |date=2019-04-19 |title=Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists |url=https://www.fredhutch.org/en/news/center-news/2019/04/greenberg-elected-american-association-immunologists.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref> * 2018 awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lectureship<ref>{{cite web |url=https://www.sitcancer.org/2018/program/annual-meeting/keynotes/greenberg}}</ref> * 2018 Gold Award for Achievement in Medical Research, Seattle Business Magazine * 2017-2020 elected Board of Directors, AACR<ref>www.fredhutch.org/en/news/center-news/2017/03/greenberg-aacr-board.html</ref> * 2015 Editor-In-Chief, Cancer Immunology Research, AACR<ref>www.fredhutch.org/en/news/center-news/2015/10/good-news-cti-overbaugh-orozco-greenberg-main.html</ref> * 2011 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, Cancer Research Institute<ref>www.fredhutch.org/en/news/center-news/2011/09/Greenberg-immunotherapy-award.html</ref> * 2008 Elected Fellow, American College of Physicians * 2007 Elected Fellow, American Association for the Advancement of Science * 1998 Elected Member, Association of American Physicians * 1991, 2007 National Institutes of Health MERIT Award * 1987 Elected Member, American Society for Clinical Investigation * 1978-1981 American Cancer Society Junior Clinical Faculty Fellowship == References == <!-- Inline citations added to your article will automatically display here. See en.wikipedia.org/wiki/WP:REFB for instructions on how to add citations. --> {{reflist}} {{Authority control}}'
Unified diff of changes made by edit (edit_diff)
'@@ -11,13 +11,69 @@ {{AfC topic|blp}} -Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the University of Washington and Head of Program in Immunology at Fred Hutch Cancer Center.<ref>{{Cite web |title=Philip D. Greenberg, M.D. |url=https://www.immunology.washington.edu/faculty/primary-joint-faculty/greenberg/ |access-date=2022-02-27 |website=Department of Immunology |publisher=[[University of Washington]] |language=en}}</ref><ref>{{Cite web |title=Philip Greenberg, M.D. |url=https://www.fredhutch.org/en/faculty-lab-directory/greenberg-philip.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref> +{{Infobox scientist +| honorific_prefix = +| name = Philip Greenberg +| honorific_suffix = +| native_name = +| native_name_lang = +| image = <!--(filename only, i.e. without "File:" prefix)--> +| image_size = +| image_upright = +| alt = +| caption = +| birth_name = <!-- if different from "name" --> +| birth_date = <!--{{birth date |YYYY|MM|DD}}--> +| birth_place = +| death_date = <!--{{death date and age |YYYY|MM|DD |YYYY|MM|DD}} (death date then birth date)--> +| death_place = +| death_cause = +| resting_place = +| resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}--> +| other_names = +| siglum = +| pronounce = +| citizenship = <!-- use only when necessary per [[WP:INFONAT]] --> +| nationality = <!-- use only when necessary per [[WP:INFONAT]] --> +| fields = [[Hematology]] +| workplaces = +| patrons = +| education = [[Washington University]], +| alma_mater = +| thesis_title = <!--(or | thesis1_title = and | thesis2_title = )--> +| thesis_url = <!--(or | thesis1_url = and | thesis2_url = )--> +| thesis_year = <!--(or | thesis1_year = and | thesis2_year = )--> +| doctoral_advisor = <!--(or | doctoral_advisors = )--> +| academic_advisors = +| doctoral_students = +| notable_students = +| known_for = +| influences = +| influenced = +| awards = +| author_abbrev_bot = +| author_abbrev_zoo = +| spouse = <!--(or | spouses = )--> +| partner = <!--(or | partners = )--> +| children = +| parents = +| father = +| mother = +| relatives = +| signature = <!--(filename only)--> +| signature_alt = +| website = <!--{{URL|www.example.com}}--> +| footnotes = +}} -Dr. Philip Greenberg graduated from Washington University with at degree in Biology. He received his M.D. summa cum laude in 1971 from the State University of New York, Downstate Medical Center. After completing postdoctoral training at the University of California at San Diego , he joined the Fred Hutchinson Cancer Research Center and the Division of Oncology at the University of Washington in 1976. +Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the [[University of Washington]] and Head of Program in Immunology at [[Fred Hutchinson Cancer Research Center]]. His research is centered around [[T cell]] biology and therapeutic cell therapies.<ref>{{cite news |title=Dr. Phil Greenberg named 2018 Leader in Health Care |url=https://www.fredhutch.org/en/news/center-news/2018/03/phil-greenberg-leader-health-care-award.html?fbclid=IwAR2b4ajtNMWgnbFaXRtr8XaZ7AfcV0zOaJ3iJ38eJr22A3EH4kfB5aDZYes |work=Fred Hutch |date=2 March 2018 |language=en}}</ref> He is a co-founder of [[Juno Therapeutics]] and Affini-T.<ref>{{cite news |title=A new biotech startup looks to sidestep a key problem with CAR-T cancer therapies |url=https://www.statnews.com/2022/01/13/cancer-immunotherapy-tcr-cart-affinit/ |work=STAT |date=13 January 2022}}</ref><ref>{{cite news |title=Leading cancer research centers team up to launch biotech startup focused on cancer immunotherapy |url=https://www.fiercebiotech.com/biotech/leading-cancer-research-centers-team-up-to-launch-biotech-startup-focused-on-cancer |work=Fierce Biotech |date=4 December 2013 |language=en}}</ref> -Awards +==Education and Research== +Philip graduated from [[Washington University]] with at degree in Biology. He received his M.D. summa cum laude in 1971 from [[SUNY Downstate Medical Center]]. After completing postdoctoral training at the [[University of California at San Diego]], he joined the Fred Hutchinson Cancer Research Center and the Division of Oncology at the University of Washington in 1976.<ref>{{cite web |url=https://www.pmwcintl.com/speaker/philip-greenberg_fred-hutchinson-cancer-research-center_2020sv/}}</ref> His research is focused on T cell adoptive immune therapy. His group demonstrated the potential of isolating antigen-specific T cells and growing them to perform in vivo activity against a disease. <ref name="ASH Award">{{cite web |title=Philip Greenberg, MD, to Present the 2019 American Society of Hematology E. Donnall Thomas Lecture |url=https://www.hematology.org/newsroom/press-releases/2019/2019-e-donnall-thomas-lecture |website=www.hematology.org |language=en}}</ref><ref>{{cite journal |last1=Riddell |first1=Stanley R. |last2=Watanabe |first2=Kathe S. |last3=Goodrich |first3=James M. |last4=Li |first4=Cheng R. |last5=Agha |first5=Mounzer E. |last6=Greenberg |first6=Philip D. |title=Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones |journal=Science |date=10 July 1992 |volume=257 |issue=5067 |pages=238–241 |doi=10.1126/science.1352912}}</ref><ref>{{cite journal |last1=Walter |first1=Elizabeth A. |last2=Greenberg |first2=Philip D. |last3=Gilbert |first3=Mark J. |last4=Finch |first4=Rosalynde J. |last5=Watanabe |first5=Käthe S. |last6=Thomas |first6=E. Donnall |last7=Riddell |first7=Stanley R. |title=Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor |journal=New England Journal of Medicine |date=19 October 1995 |volume=333 |issue=16 |pages=1038–1044 |doi=10.1056/NEJM199510193331603}}</ref> His group is now working on re-engineering T cells to produce [[T cell receptor T cell therapy|TCR-T]] that will work for other non-leukemia malignancies.<ref name="Spotlight on Phil Greenberg">{{cite web |title=Spotlight on Phil Greenberg |url=https://www.fredhutch.org/en/faculty-lab-directory/greenberg-philip/greenberg-spotlight.html?&link=sfb |website=Fred Hutch |language=en}}</ref> -* 2019 E.Donnall Thomas Lecture and Prize, American Society of Hematology -* 2019 elected a Distinguished Fellow of the American Association of Immunologists<ref>{{Cite web |date=2019-04-19 |title=Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists |url=https://www.fredhutch.org/en/news/center-news/2019/04/greenberg-elected-american-association-immunologists.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref> -* 2018 awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lectureship<ref>https://centernet.fredhutch.org/cn/n/2018/11/cancer-immunotherapy-sitc-awards.html</ref> +==Awards== + +* 2019 E. Donnall Thomas Lecture and Prize, [[American Society of Hematology]]<ref name="ASH Award" /> +* 2019 Elected a Distinguished Fellow of the American Association of Immunologists<ref>{{Cite web |date=2019-04-19 |title=Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists |url=https://www.fredhutch.org/en/news/center-news/2019/04/greenberg-elected-american-association-immunologists.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref> +* 2018 awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lectureship<ref>{{cite web |url=https://www.sitcancer.org/2018/program/annual-meeting/keynotes/greenberg}}</ref> * 2018 Gold Award for Achievement in Medical Research, Seattle Business Magazine * 2017-2020 elected Board of Directors, AACR<ref>www.fredhutch.org/en/news/center-news/2017/03/greenberg-aacr-board.html</ref> @@ -27,8 +83,12 @@ * 2007 Elected Fellow, American Association for the Advancement of Science * 1998 Elected Member, Association of American Physicians -* 1991-2007 National Institutes of Health MERIT Award +* 1991, 2007 National Institutes of Health MERIT Award * 1987 Elected Member, American Society for Clinical Investigation * 1978-1981 American Cancer Society Junior Clinical Faculty Fellowship + + == References == <!-- Inline citations added to your article will automatically display here. See en.wikipedia.org/wiki/WP:REFB for instructions on how to add citations. --> {{reflist}} + +{{Authority control}} '
New page size (new_size)
7914
Old page size (old_size)
3370
Size change in edit (edit_delta)
4544
Lines added in edit (added_lines)
[ 0 => '{{Infobox scientist', 1 => '| honorific_prefix = ', 2 => '| name = Philip Greenberg ', 3 => '| honorific_suffix = ', 4 => '| native_name = ', 5 => '| native_name_lang = ', 6 => '| image = <!--(filename only, i.e. without "File:" prefix)-->', 7 => '| image_size = ', 8 => '| image_upright = ', 9 => '| alt = ', 10 => '| caption = ', 11 => '| birth_name = <!-- if different from "name" -->', 12 => '| birth_date = <!--{{birth date |YYYY|MM|DD}}-->', 13 => '| birth_place = ', 14 => '| death_date = <!--{{death date and age |YYYY|MM|DD |YYYY|MM|DD}} (death date then birth date)-->', 15 => '| death_place = ', 16 => '| death_cause = ', 17 => '| resting_place = ', 18 => '| resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}-->', 19 => '| other_names = ', 20 => '| siglum =', 21 => '| pronounce =', 22 => '| citizenship = <!-- use only when necessary per [[WP:INFONAT]] -->', 23 => '| nationality = <!-- use only when necessary per [[WP:INFONAT]] -->', 24 => '| fields = [[Hematology]]', 25 => '| workplaces = ', 26 => '| patrons = ', 27 => '| education = [[Washington University]],', 28 => '| alma_mater = ', 29 => '| thesis_title = <!--(or | thesis1_title = and | thesis2_title = )-->', 30 => '| thesis_url = <!--(or | thesis1_url = and | thesis2_url = )-->', 31 => '| thesis_year = <!--(or | thesis1_year = and | thesis2_year = )-->', 32 => '| doctoral_advisor = <!--(or | doctoral_advisors = )-->', 33 => '| academic_advisors = ', 34 => '| doctoral_students = ', 35 => '| notable_students = ', 36 => '| known_for = ', 37 => '| influences = ', 38 => '| influenced = ', 39 => '| awards = ', 40 => '| author_abbrev_bot = ', 41 => '| author_abbrev_zoo = ', 42 => '| spouse = <!--(or | spouses = )-->', 43 => '| partner = <!--(or | partners = )-->', 44 => '| children = ', 45 => '| parents =', 46 => '| father =', 47 => '| mother =', 48 => '| relatives =', 49 => '| signature = <!--(filename only)-->', 50 => '| signature_alt = ', 51 => '| website = <!--{{URL|www.example.com}}-->', 52 => '| footnotes = ', 53 => '}}', 54 => 'Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the [[University of Washington]] and Head of Program in Immunology at [[Fred Hutchinson Cancer Research Center]]. His research is centered around [[T cell]] biology and therapeutic cell therapies.<ref>{{cite news |title=Dr. Phil Greenberg named 2018 Leader in Health Care |url=https://www.fredhutch.org/en/news/center-news/2018/03/phil-greenberg-leader-health-care-award.html?fbclid=IwAR2b4ajtNMWgnbFaXRtr8XaZ7AfcV0zOaJ3iJ38eJr22A3EH4kfB5aDZYes |work=Fred Hutch |date=2 March 2018 |language=en}}</ref> He is a co-founder of [[Juno Therapeutics]] and Affini-T.<ref>{{cite news |title=A new biotech startup looks to sidestep a key problem with CAR-T cancer therapies |url=https://www.statnews.com/2022/01/13/cancer-immunotherapy-tcr-cart-affinit/ |work=STAT |date=13 January 2022}}</ref><ref>{{cite news |title=Leading cancer research centers team up to launch biotech startup focused on cancer immunotherapy |url=https://www.fiercebiotech.com/biotech/leading-cancer-research-centers-team-up-to-launch-biotech-startup-focused-on-cancer |work=Fierce Biotech |date=4 December 2013 |language=en}}</ref>', 55 => '==Education and Research==', 56 => 'Philip graduated from [[Washington University]] with at degree in Biology. He received his M.D. summa cum laude in 1971 from [[SUNY Downstate Medical Center]]. After completing postdoctoral training at the [[University of California at San Diego]], he joined the Fred Hutchinson Cancer Research Center and the Division of Oncology at the University of Washington in 1976.<ref>{{cite web |url=https://www.pmwcintl.com/speaker/philip-greenberg_fred-hutchinson-cancer-research-center_2020sv/}}</ref> His research is focused on T cell adoptive immune therapy. His group demonstrated the potential of isolating antigen-specific T cells and growing them to perform in vivo activity against a disease. <ref name="ASH Award">{{cite web |title=Philip Greenberg, MD, to Present the 2019 American Society of Hematology E. Donnall Thomas Lecture |url=https://www.hematology.org/newsroom/press-releases/2019/2019-e-donnall-thomas-lecture |website=www.hematology.org |language=en}}</ref><ref>{{cite journal |last1=Riddell |first1=Stanley R. |last2=Watanabe |first2=Kathe S. |last3=Goodrich |first3=James M. |last4=Li |first4=Cheng R. |last5=Agha |first5=Mounzer E. |last6=Greenberg |first6=Philip D. |title=Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones |journal=Science |date=10 July 1992 |volume=257 |issue=5067 |pages=238–241 |doi=10.1126/science.1352912}}</ref><ref>{{cite journal |last1=Walter |first1=Elizabeth A. |last2=Greenberg |first2=Philip D. |last3=Gilbert |first3=Mark J. |last4=Finch |first4=Rosalynde J. |last5=Watanabe |first5=Käthe S. |last6=Thomas |first6=E. Donnall |last7=Riddell |first7=Stanley R. |title=Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor |journal=New England Journal of Medicine |date=19 October 1995 |volume=333 |issue=16 |pages=1038–1044 |doi=10.1056/NEJM199510193331603}}</ref> His group is now working on re-engineering T cells to produce [[T cell receptor T cell therapy|TCR-T]] that will work for other non-leukemia malignancies.<ref name="Spotlight on Phil Greenberg">{{cite web |title=Spotlight on Phil Greenberg |url=https://www.fredhutch.org/en/faculty-lab-directory/greenberg-philip/greenberg-spotlight.html?&link=sfb |website=Fred Hutch |language=en}}</ref> ', 57 => '==Awards==', 58 => '', 59 => '* 2019 E. Donnall Thomas Lecture and Prize, [[American Society of Hematology]]<ref name="ASH Award" />', 60 => '* 2019 Elected a Distinguished Fellow of the American Association of Immunologists<ref>{{Cite web |date=2019-04-19 |title=Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists |url=https://www.fredhutch.org/en/news/center-news/2019/04/greenberg-elected-american-association-immunologists.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref>', 61 => '* 2018 awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lectureship<ref>{{cite web |url=https://www.sitcancer.org/2018/program/annual-meeting/keynotes/greenberg}}</ref>', 62 => '* 1991, 2007 National Institutes of Health MERIT Award', 63 => '', 64 => '', 65 => '', 66 => '{{Authority control}}' ]
Lines removed in edit (removed_lines)
[ 0 => 'Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the University of Washington and Head of Program in Immunology at Fred Hutch Cancer Center.<ref>{{Cite web |title=Philip D. Greenberg, M.D. |url=https://www.immunology.washington.edu/faculty/primary-joint-faculty/greenberg/ |access-date=2022-02-27 |website=Department of Immunology |publisher=[[University of Washington]] |language=en}}</ref><ref>{{Cite web |title=Philip Greenberg, M.D. |url=https://www.fredhutch.org/en/faculty-lab-directory/greenberg-philip.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref>', 1 => 'Dr. Philip Greenberg graduated from Washington University with at degree in Biology. He received his M.D. summa cum laude in 1971 from the State University of New York, Downstate Medical Center. After completing postdoctoral training at the University of California at San Diego , he joined the Fred Hutchinson Cancer Research Center and the Division of Oncology at the University of Washington in 1976.', 2 => 'Awards', 3 => '* 2019 E.Donnall Thomas Lecture and Prize, American Society of Hematology', 4 => '* 2019 elected a Distinguished Fellow of the American Association of Immunologists<ref>{{Cite web |date=2019-04-19 |title=Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists |url=https://www.fredhutch.org/en/news/center-news/2019/04/greenberg-elected-american-association-immunologists.html |access-date=2022-02-27 |website=Fred Hutch |language=en}}</ref>', 5 => '* 2018 awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lectureship<ref>https://centernet.fredhutch.org/cn/n/2018/11/cancer-immunotherapy-sitc-awards.html</ref>', 6 => '* 1991-2007 National Institutes of Health MERIT Award' ]
Whether or not the change was made through a Tor exit node (tor_exit_node)
false
Unix timestamp of change (timestamp)
'1658236084'